Evaluation of melatonin levels after COVID-19 in Yakutsk residents
https://doi.org/10.25789/YMJ.2022.79.17
Abstract
The article presents the results of assessing the level of melatonin after Covid-19 in residents of Yakutsk. It was found that after the coronavirus infection, there is a decrease in the level of melatonin. Coronavirus infection affects the production of melatonin, which subsequently leads to disruption of vital rhythms.
About the Authors
A. A. Grigorieva
FBSI Yakut Sscientific Centre of Complex Medical Problems
Russian Federation
Russian Federation
Grigorieva Anastasia Anatolyevna – MD, Arctic Medical Center
E. D. Okhlopkova
FBSI Yakut Sscientific Centre of Complex Medical Problems
Russian Federation
Russian Federation
Okhlopkova Elena Dmitrievna – Ph.D of Biology, senior researcher
L. D. Olesova
FBSI Yakut Sscientific Centre of Complex Medical Problems
Russian Federation
Russian Federation
Olesova Lyubov Dygynovna – PhD of Biology, visiting research fellow, head of the Lab
S. D. Efremova
FBSI Yakut Sscientific Centre of Complex Medical Problems
Russian Federation
Russian Federation
Efremova Svetlana Dmitrievna – junior researcher
References
1. Berezova D.T. Melatonin: properties, biorhythms and possibilities of use in medicine/ Berezova D.T. // Vladikavkaz medical and biological bulletin. - 2012. - 23. - P. 127-133.
2. Danilov A.B. Melatonin is a unique molecule? / A.B. Danilov, Yu.M. Kurganov // Effective pharmacotherapy. Neurology and psychiatry. 2013. – No. 1. - P. 26-30.
3. M.V. Tardov. Insomnia at Covid-19 / M.V. Tardov, M.G. Semiectov // Effective pharmacotherapy. - 2021. - Volume: 17 33. - P. 36-41. doi: 10.33978/2307-3586-2021-17-33-36-41.
4. Anderson G. Melatonin: roles in influenza, Covid-19, and other viral infections. / G. Anderson, RJ. Reiter. // Rev Med Virol. (2020) May;30(3):e2109. doi: 10.1002/rmv.2109.
5. Abdelhady A. COVID-19-associated sleep disorders: A case report // Neurobiol Sleep Circadian Rhythms. 2020. Vol. 9, no. 2. P. 3–5. DOI: 10.1016/j.nbscr.2020.100057.
6. Asmundson G.J. Coronaphobia: Fear and the 2019-nCoV outbreak / G.J. Asmundson, S. Taylor // Journal of Anxiety Disorders. 2020. Vol. 70. Р. 10–21. DOI: 10.1016/j.janxdis.2020.102196.
7. A review of sleep disorders and melatonin / Z. Xie, F. Chen, A. Li William, et al. // A Journal of Progress in Neurosurgery, Neurology and Neurosciences Volume 39, 2017 - Issue Pages 559-565 doi.org/10.1080/01616412.2017.1315864
8. Besedovsky L. The sleep-immune crosstalk in health and disease / L. Besedovsky, T. Lange, M. Haack // Physiol. Rev. 2019. Vol. 99, No. 10. Р. 1325–1380. DOI: 10.1152/physrev.00010.2018
9. Infections, pandemics and sleep disorders / O.V. Kolokolov, E.A.Salina, V.V. Yudina, A.A. et al. // Zh Nevrol Psikhiatr Im S.S. Korsakova. 2021;121(4. Vyp. 2): p. 68-74. doi: 10.17116/jnevro202112104268
10. Ibarra-Coronado E.G. The Bidirectional Relationship between Sleep and Immunity against Infections. / E.G. Ibarra-Coronado, A.M. Pantaleón-Martínez // J. Immunol Res. 2015. Vol. 3, no. 1. Р. 67–75. DOI: 10.1155/2015/678164
11. Jarrott B. “LONG COVID”—A hypothesis forunderstanding the biological basis and pharmacological treatment strategy. / B. Jarrott, R. Head, KG. Pringle, et al. // Pharmacol Res Perspect. 2022;10:e00911. doi:10.1002/prp2.911
12. Melatonin effects on sleep quality and outcomes of COVID-19 patients: An open-label, randomized, controlled trial / S. A. Mousavi, K. Heydari, H. Mehravaran, et al. // J Med Virol. 2022 Jan;94(1): p. 263-271. doi: 10.1002/jmv.27312.
13. Richter K. Sleep quality and COVID-19 outcomes: the evidence-based lessons in the framework of predictive, preventive and personalised (3P) medicine/ K. Richter, S. Kellner, T. Hillemacher, et al. // EPMA J. 2021 Jun 8;12(2): p.221-241. doi: 10.1007/s13167-021-00245-2
14. Rubin R.T. Neuroendocrine aspects of primary endogenous depression. XI. Serum melatonin measures in patients and matched control subjects / R.T. Rubin, E.K. Heist, S.S. McGeoy et al. // Arch. Gen. Psychiatry. 1992. Vol. 49. № 7. P. 558–567. DOI: 10.1001/archpsyc.1992.01820070052008
15. Shneider A. Can melatonin reduce the severity of COVID-19 pandemic? / A. Shneider, A. Kudriavtsev, A. Vakhrusheva // Int Rev Immunol (2020 Apr 29), p. 1-10. doi.org/10.1080/08830185.2020.1756284
16. Zhang R. COVID-19: Melatonin as a potential adjuvant treatment. / R. Zhang, X. Wang, L. Ni et al. // Life Sci. (2020) 250:11758. doi: 10.1016/j.lfs.2020.117583
17. Zambrelli E. Delirium and sleep disturbances in COVID-19: a possible role for melatonin in hospitalized patients? / E. Zambrelli, M. Canevini, O. Gambini, et al. // Sleep Med, 70 (2020 Apr 17), p. 111. doi.org/10.1016/j.sleep.2020.04.006
18. Zhang R. COVID-19: melatonin as a potential adjuvant treatment / R. Zhang, X. Wang, L. Ni, et al. // Life Sci, 250 (2020 Jun 1), p. 1-6. DOI: 10.1016/j.lfs.2020.117583
Review
For citations:
Grigorieva A.A., Okhlopkova E.D., Olesova L.D., Efremova S.D. Evaluation of melatonin levels after COVID-19 in Yakutsk residents. Yakut Medical Journal. 2022;(3):65-68. https://doi.org/10.25789/YMJ.2022.79.17
Views:
23
Email this article 